Arrowhead Research | Nettoeinkommen





Nettoeinkommen Veränderung Datum
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Anika Therapeutics USD -4.87M 16.99M 2025-03
Arrowhead Research USD 30.81M 54.56M 2025-12
Heron Therapeutics USD -4.85M 4.39M 2024-09
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Novartis USD 3.93B 96M 2025-09
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
TG Therapeutics USD 390.9M 362.71M 2025-09
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Xencor USD -6.03M 24.8M 2025-09


Arrowhead Research Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.